The single-cell multi-omics market size was valued at USD 6 billion in 2025 and is projected to grow from USD 7 billion in 2026 to USD 22 billion by 2034 at a CAGR of 19% during the forecast period 2026-2034. North America dominated the single-cell multi-omics market with a market share of 42.5% in 2025.
Single-cell multi-omics is an advanced research approach that studies multiple types of biological information, such as genes, RNA, proteins, and epigenetic changes, from a single cell at the same time. It helps researchers better understand cell function, disease progression, and treatment response. Demand is growing due to increasing investments in precision medicine, cancer research, drug discovery, and advanced genomic technologies.
Download a Free Sample To learn more about this report,
Growing Adoption of Single-Cell Analysis in Precision Medicine
Single-Cell Multi-Omics Market trends are being driven by the increasing use of single-cell technologies to better understand complex diseases at the cellular level. Researchers are combining genomics, transcriptomics, proteomics, and epigenomics to study individual cells instead of analyzing bulk tissue samples. This approach is helping scientists identify disease mechanisms more accurately, improve biomarker discovery, and develop personalized treatments for cancer, autoimmune disorders, and neurological diseases. Pharmaceutical and biotechnology companies are also investing heavily in single-cell research to accelerate drug discovery and clinical development. These developments are supporting single-cell multi-omics market growth as precision medicine continues to advance.
Rising Innovation in AI-Driven Data Analysis and Integrated Multi-Omics Platforms
Single-Cell Multi-Omics Market trends are also being influenced by advances in artificial intelligence and integrated analytical platforms. As single-cell experiments generate massive datasets, researchers are increasingly using AI-powered software to process complex biological information more quickly and accurately. At the same time, instrument manufacturers are launching integrated platforms that combine sample preparation, sequencing, and data analysis into a single workflow, improving laboratory efficiency. These innovations are strengthening single-cell multi-omics market share by making advanced single-cell analysis more accessible for academic research, pharmaceutical development, and clinical applications.
Growing Need for Precision Medicine and Advanced Genomics Research
The single-cell multi-omics market is growing rapidly as researchers seek a deeper understanding of complex diseases at the cellular level. By analyzing multiple biological molecules from a single cell, this technology helps scientists study cancer, neurological disorders, immune diseases, and rare genetic conditions with greater accuracy. Rising investments in precision medicine, genomics research, and drug discovery are strengthening single-cell multi-omics market demand. The increasing use of advanced sequencing technologies is also supporting market growth.
High Technology Costs and Complex Data Analysis
The single-cell multi-omics market faces challenges because the technology requires expensive instruments, specialized laboratory equipment, and advanced bioinformatics tools. Processing and interpreting large amounts of multi-omics data also requires skilled professionals and significant computing resources. These factors can limit adoption among smaller research laboratories and healthcare institutions with limited budgets.
Expansion of Personalized Medicine and Clinical Research
The single-cell multi-omics market offers strong opportunities as pharmaceutical companies and research organizations increasingly use this technology to identify disease biomarkers, develop targeted therapies, and improve clinical decision-making. Growing collaborations between biotechnology companies, academic institutions, and healthcare providers are accelerating innovation in precision medicine. These developments are expected to strengthen single-cell multi-omics market share over the coming years.
Standardizing Workflows and Managing Large Datasets
The single-cell multi-omics market continues to face challenges in creating standardized laboratory workflows and ensuring consistent results across different research settings. Large datasets require powerful computing infrastructure, advanced software, and experienced data scientists for accurate interpretation. Manufacturers must also improve workflow automation, reduce operating costs, and make these technologies easier to use. Continued investment in data analysis platforms, automation, and collaborative research will be essential for long-term market growth.
Request Customizationto receive a tailored report.
Single-cell Genomics Segment Dominated the Market with 34.6% Share in 2025
The single-cell genomics segment dominated the global single-cell multi-omics market with a 34.6% share in 2025. Researchers widely use single-cell genomics to study genetic variations at the individual cell level, helping them better understand complex diseases and identify potential treatment targets. Increasing investment in precision medicine and genomics research continues to support the growth of this segment.
The single-cell transcriptomics and single-cell proteomics segments are also growing steadily. Transcriptomics helps researchers understand gene expression in individual cells, while proteomics provides detailed information about protein activity and cellular functions. Both technologies are becoming essential tools in cancer research, drug discovery, and disease diagnosis.
The single-cell metabolomics segment is expanding rapidly as scientists increasingly study cellular metabolism to understand disease progression and treatment response. Continuous improvements in sequencing technologies and analytical tools are expected to drive growth across all multi-omics approaches.
Oncology Segment Dominated the Market with 39.8% Share in 2025
The oncology segment dominated the global single-cell multi-omics market with a 39.8% share in 2025. Single-cell multi-omics technologies are helping researchers better understand tumor biology, identify cancer biomarkers, and develop more personalized treatment strategies. The increasing focus on precision oncology continues to make this the largest application segment.
The cell biology and immunology segments are also growing steadily as researchers use multi-omics tools to study cell behavior, immune responses, and disease mechanisms in greater detail. Neurology is also seeing increasing adoption as scientists investigate neurological disorders at the single-cell level to improve diagnosis and develop new therapies.
Growing research funding, advances in sequencing technologies, and the rising demand for personalized medicine are expected to support growth across all application areas.
Single Cell Analysis Segment Dominated the Market with 56.3% Share in 2025
The single cell analysis segment dominated the global single-cell multi-omics market with a 56.3% share in 2025. This technique allows researchers to examine the genetic, molecular, and functional characteristics of individual cells, providing deeper insights into disease development and biological processes. Its broad use in life science research continues to drive market growth.
The single cell isolation & dispensing segment is also growing steadily as accurate isolation of individual cells remains the first and most important step in single-cell analysis. Advances in microfluidics, automated platforms, and high-throughput technologies are making cell isolation faster and more reliable.
As laboratories continue to adopt integrated multi-omics workflows, demand for both isolation and analysis technologies is expected to increase over the forecast period.
Academic Institutes Segment Dominated the Market with 41.2% Share in 2025
The academic institutes segment dominated the global single-cell multi-omics market with a 41.2% share in 2025. Universities and research institutions are leading the adoption of single-cell multi-omics technologies as they conduct studies on genetics, cancer biology, immunology, and other complex diseases. Strong government funding and collaborative research projects continue to support this segment.
The pharmaceutical & biotech companies and contract research organizations (CROs) segments are also growing steadily. Pharmaceutical and biotechnology companies are using single-cell technologies to accelerate drug discovery and biomarker identification, while CROs are expanding their service offerings to support growing demand for advanced research and clinical studies.
Increasing collaboration between academic institutions, healthcare organizations, and the biopharmaceutical industry is expected to drive innovation and support long-term growth across all end-user segments.
Speak to an Analystto discuss market opportunities.
North America single-cell multi-omics market accounted for 42.5% of the global market, reaching USD 2.55 billion in 2025, and is projected to grow at a CAGR of 16.8% during the forecast period. The market is expanding rapidly due to increasing investments in precision medicine, rising genomics research, and growing demand for advanced single-cell analysis technologies. Strong research funding and the presence of leading biotechnology companies are also supporting market growth.
The U.S. market was valued at USD 2.17 billion in 2025, making it the largest contributor in North America. Growing investment in genomics research, increasing adoption of advanced sequencing technologies, and strong government support for precision medicine continue to drive market growth.
Canada's market reached USD 0.38 billion in 2025. Rising research funding, expanding biotechnology sector, and increasing collaboration between academic institutes and healthcare organizations continue to support steady market growth.
Europe single-cell multi-omics market accounted for 27.3% of the global market, reaching USD 1.64 billion in 2025, and is expected to register a CAGR of 16.2% during the forecast period. Growing investment in life science research, increasing focus on personalized medicine, and rising adoption of advanced molecular analysis technologies are supporting market growth. Collaboration between research institutes and biotechnology companies is also helping the market expand.
Germany's market accounted for USD 0.48 billion in 2025. Strong biomedical research, increasing investment in genomics, and growing demand for advanced analytical technologies continue to support market growth.
The UK market was valued at USD 0.33 billion in 2025. Expanding genomics research programs, increasing government funding, and rising use of precision medicine continue to contribute to market growth.
Asia Pacific single-cell multi-omics market accounted for 21.4% of the global market, valued at USD 1.28 billion in 2025, and is projected to register a CAGR of 20.7% during the forecast period. Growing healthcare investments, expanding biotechnology research, and increasing adoption of advanced sequencing technologies are driving market growth across the region. Government support for life science innovation is also creating new opportunities.
Japan's market generated USD 0.23 billion in 2025. Strong research capabilities, increasing focus on precision medicine, and rising investment in biotechnology continue to support market growth.
China's market accounted for USD 0.67 billion in 2025, representing the largest share within Asia Pacific. Expanding genomics research, increasing biotechnology investments, and growing demand for advanced single-cell analysis technologies continue to drive market growth.
Latin America single-cell multi-omics market accounted for 5.1% of the global market, reaching USD 0.31 billion in 2025, and is projected to grow at a CAGR of 15.4% during the forecast period. Improving research infrastructure, increasing investment in biotechnology, and growing interest in precision medicine are supporting market growth across the region.
Brazil's market reached USD 0.16 billion in 2025. Rising investment in life science research, expanding academic collaborations, and increasing adoption of advanced molecular technologies continue to create growth opportunities.
Middle East & Africa single-cell multi-omics market accounted for 3.7% of the global market, totaling USD 0.22 billion in 2025, and is anticipated to grow at a CAGR of 14.8% during the forecast period. Growing investment in biomedical research, improving healthcare infrastructure, and increasing focus on precision medicine are supporting market growth across the region.
The UAE market was valued at USD 0.08 billion in 2025. Government investment in biotechnology, expanding research facilities, and increasing adoption of advanced genomic technologies continue to support market growth.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Associate
Mitiksha Koul is a Research Associate with 2 years of experience in market research. She focuses on analyzing industry trends, competitive landscapes, and growth opportunities to support strategic decision-making. Mitiksha’s strong analytical skills and research expertise enable her to deliver actionable insights that help businesses adapt to evolving market dynamics and achieve sustainable growth.
We are featured on:
sales@straitsresearch.com